Recombinant FCGRT (Rozanolixizumab Biosimilar) antibody
Research Grade
Reactivity: Human
ELISA, WB
Host: Humanized
Chimeric
unconjugated
Recombinant Antibody
-
- Target
- FCGRT (Rozanolixizumab Biosimilar)
- Antibody Type
- Recombinant Antibody
- Reactivity
- Human
- Host
-
Humanized
- Expression System
- Mammalian cells
- Clonality
- Chimeric
- Application
- ELISA, Western Blotting (WB)
- Purpose
- Rozanolixizumab Biosimilar - Anti-FCGRT mAb - Research Grade
- Characteristics
- Antibody Type: IgG4-kappa
- Purification
- Recombinant antibody expressed in mammalien cells and purified.
- Purity
- > 85%
- Grade
- Research Grade
- Isotype
- IgG4
-
- Restrictions
- For Research Use only
-
- Buffer
- PBS buffer PH7.5
- Storage
- -80 °C
- Storage Comment
- store at -80°C
-
- Target
- FCGRT (Rozanolixizumab Biosimilar)
- Target Type
- Biosimilar
- Background
- Rozanolixizumab, a humanized high-affinity anti-human neonatal Fc receptor (FcRn) monoclonal antibody (IgG4P), is used to the research of reducing pathogenic IgG in autoimmune and alloimmune diseases.
- CAS-No
- 1584645-37-3
-
You are here:
